BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1523 related articles for article (PubMed ID: 27868281)

  • 1. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
    Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
    Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
    Trad KS; Turgeon DG; Deljkich E
    Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.
    Ihde GM; Besancon K; Deljkich E
    Am J Surg; 2011 Dec; 202(6):740-6; discussion 746-7. PubMed ID: 22014853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
    Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
    Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral Incisionless Fundoplication TIF 2.0 with "EsophyX Z®" Device for GERD: Seven Years after Endo Lumenal Fundoplication. World’s First Case Report.
    Nicolau AE; Lobonţiu A
    Chirurgia (Bucur); 2018; 113(6):849-856. PubMed ID: 30596372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD.
    Frazzoni M; Conigliaro R; Manta R; Melotti G
    Aliment Pharmacol Ther; 2011 Jul; 34(1):67-75. PubMed ID: 21539587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.
    Bell RC; Freeman KD
    Surg Endosc; 2011 Jun; 25(6):1975-84. PubMed ID: 21140170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
    Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
    World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
    Testoni PA; Corsetti M; Di Pietro S; Castellaneta AG; Vailati C; Masci E; Passaretti S
    World J Surg; 2010 Apr; 34(4):750-7. PubMed ID: 20091308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.
    Cadière GB; Van Sante N; Graves JE; Gawlicka AK; Rajan A
    Surg Endosc; 2009 May; 23(5):957-64. PubMed ID: 19288158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
    Chimukangara M; Jalilvand AD; Melvin WS; Perry KA
    Surg Endosc; 2019 Apr; 33(4):1304-1309. PubMed ID: 30167944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.